The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

“CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in ...

Guggenheim Securities adjusted its price target for Immunovant shares, listed on (NASDAQ:IMVT), to $44.00, a decrease from the previous $46.00, while sustaining a Buy rating on the stock. Currently ...

H.C. Wainwright reaffirmed their Buy rating on Immunovant (NASDAQ:IMVT) shares with a price target of $51.00, aligning with the broader Wall Street sentiment. According to InvestingPro data, analyst ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Albert Fiori was diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy or CIDP, a rare autoimmune disease that affects his eye, one arm and one leg. But he is not letting that stop him from ...

BofA raised the firm’s price target on Argenx (ARGX) to $774 from $770 and keeps a Buy rating on the shares. The company pre-announced Q4 ...

THE family of a "beloved father and husband" who took his own life after Covid-19 vaccine complications are fighting for justice.

Jaimie Sheil, from Melbourne, Australia, was diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) when she was 23 years old. Prior to her illness, she was a PhD student studying ...

Inflammatory disorders often cause myelin damage, but there are other causes. When you think of myelin, imagine the insulation around an electrical wire. Damage to myelin can make it harder for ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...